Glass House Brands Inc. Subordinate Voting Shares (GLAS)
GLAS trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 40-F (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1848731/000184873126000015/0001848731-26-000015-index.htm. Net income: SEC 40-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | GLAS on NYSE |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Not reported by the screener |
| IPO year | Not reported by the screener |
| SEC CIK | 0001848731 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | BC |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $182.0M |
| Net income | -$29.7M |
| Operating income | -$16.5M |
| Net margin | -16.3% |
| Operating margin | -9.1% |
| Revenue growth | -9.4% |
| Cash | $23.4M |
| Total assets | $318.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 40-F 2026-03-24 |
| Cash and burn | $23.4M cash; operating cash flow $2.9M a quarter. | Report 2025-12-31 |
| Shares outstanding | 80,037,887 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Macias Gini & O'Connell LLP, Irvine, California, United States | PCAOB Form AP 2026-04-01 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $354K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $182.0M | -$29.7M | $11.4M | $23.4M | $68.7M | $182.0M | 40-F 2026-03-24 |
| FY 2024 2024-12-31 | $200.9M | $519K | $28.4M | $36.9M | $58.2M | $200.9M | 40-F 2026-03-24 |
| FY 2023 2023-12-31 | $160.8M | -$98.3M | $23.2M | $32.5M | $64.1M | $160.8M | 40-F 2025-03-25 |
| FY 2022 2022-12-31 | $84.9M | -$32.9M | -$40.8M | $14.1M | $62.7M | $84.9M | 40-F/A 2024-04-02 |
| FY 2021 2021-12-31 | $63.2M | -$43.1M | -$20.3M | $54.1M | $44.9M | $63.2M | 40-F/A 2024-04-02 |
| FY 2020 2020-12-31 | $48.3M | -$16.7M | -$7.7M | $4.5M | $16.0M | $48.3M | 40-F/A 2022-04-01 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-03-24 |
| Latest quarterly / interim | 6-K | 2026-11-16 |
Source: SEC EDGAR submissions feed, 197 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -38.9% |
| 1 month | -67.0% |
| 3 months | -87.3% |
| Year to date | -85.6% |
| 1 year | -81.9% |
| From 52-week high | -90.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ISPR | Ispire Technology Inc. | $1.52 | -10.06% | $87.8M |
| NAGE | Niagen Bioscience Inc. | $2.01 | -2.66% | $159.2M |
| MDWD | MediWound Ltd. | $13.55 | +5.04% | $195.0M |
| FTLF | FitLife Brands Inc. | $6.83 | -19.46% | $64.1M |
| CGC | Canopy Growth Corporation Common Shares | $0.5460 | -2.71% | $231.2M |
| USNA | USANA Health Sciences Inc. | $13.54 | +2.27% | $250.3M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.61 | -6.68% | $303.1M |
| SNDL | SNDL Inc. Common Shares | $1.34 | -2.19% | $326.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier